GLP-1MK-801 versus semaglutide To further scrutinize the translational potential of GLP-1MK-801, we benchmarked it against semaglutide, a pharmacokinetically optimized GLP-1 receptor agonist approved for treatment of obesity and clinically available as a once-weekly injectable 33
In the animal model, GCs administration decreased the mRNA expression of preproglucagon, the precursor of GLP-1 (10, 11)
Telehealth platforms like Felix Health, Maple and our top pick MyRocky have made getting a prescription faster than the clinic route, and several now dispense the generic at $149 a month
They are often marketed as needle-free alternatives to prescription GLP-1 injections and may be described as Wegovy patches or Mounjaro patches
As the obesity drug pipeline expands from semaglutide and tirzepatide to triple agonists, oral formulations, and biased agonists, the side effect profiles are diverging in important ways
Social media defenses After the feedback from the New York Times piece was decidedly mixed, Gallagher has taken to social media to defend the company